Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acetylcholinesterase inhibitors targeting the cholinergic anti-inflammatory pathway: a new therapeutic perspective in aging-related disorders
Roberta Benfante, Simona Di Lascio, Silvia Cardani, et al.
Aging Clinical and Experimental Research (2019) Vol. 33, Iss. 4, pp. 823-834
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Kaempferol: Paving the path for advanced treatments in aging-related diseases
Md Sadique Hussain, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Afzal, et al.
Experimental Gerontology (2024) Vol. 188, pp. 112389-112389
Open Access | Times Cited: 50
Neuroprotective Effects of Cholinesterase Inhibitors: Current Scenario in Therapies for Alzheimer’s Disease and Future Perspectives
Natália Moreira, Jéssica Ellen Barbosa de Freitas Lima, Marcelo Fiori Marchiori, et al.
Journal of Alzheimer s Disease Reports (2022) Vol. 6, Iss. 1, pp. 177-193
Open Access | Times Cited: 59
Neuroimmune nexus in the pathophysiology and therapy of inflammatory disorders: Role of α7 nicotinic acetylcholine receptors
Kasey R. Keever, Valentin P. Yakubenko, Donald B. Hoover
Pharmacological Research (2023) Vol. 191, pp. 106758-106758
Open Access | Times Cited: 25
Imine-Linked Covalent Organic Framework Modulates Oxidative Stress in Alzheimer’s Disease
Qingfan Ren, Huiting Chen, Yuying Chen, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 4, pp. 4947-4958
Closed Access | Times Cited: 24
Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway
Xiaoxiao Shan, Wenwen Tao, Junying Li, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118145-118145
Closed Access | Times Cited: 12
Sinomenine regulates the cholinergic anti-inflammatory pathway to inhibit TLR4/NF-κB pathway and protect the homeostasis in brain and gut in scopolamine-induced Alzheimer’s disease mice
H. Ni, Muqiu Liu, Mindie Cao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116190-116190
Open Access | Times Cited: 10
Multipotent Effect of Clozapine on Lipopolysaccharide-Induced Acetylcholinesterase, Cyclooxygenase-2,5-Lipoxygenase, and Caspase-3: In Vivo and Molecular Modeling Studies
Minhajul Arfeen, Devendra K. Dhaked, Vasudevan Mani
Molecules (2025) Vol. 30, Iss. 2, pp. 266-266
Open Access | Times Cited: 1
Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
Nidhi Puranik, Minseok Song
Neurology International (2025) Vol. 17, Iss. 2, pp. 26-26
Open Access | Times Cited: 1
A Novel Targeted and High‐Efficiency Nanosystem for Combinational Therapy for Alzheimer's Disease
Han Yang, Weihang Mu, Daohe Wei, et al.
Advanced Science (2020) Vol. 7, Iss. 19
Open Access | Times Cited: 59
Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer’s disease
Xiaohang Qian, Xiaoli Liu, Guang Chen, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 32
Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules
Nassima Oumata, Kui Lu, Yuou Teng, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114578-114578
Closed Access | Times Cited: 29
S-adenosylmethionine improves cognitive impairment in D-galactose-induced brain aging by inhibiting oxidative stress and neuroinflammation
Yawen Zhang, Rui Ma, Qian Deng, et al.
Journal of Chemical Neuroanatomy (2023) Vol. 128, pp. 102232-102232
Closed Access | Times Cited: 17
A distinctive subgingival microbiome in patients with periodontitis and Alzheimer's disease compared with cognitively unimpaired periodontitis patients
Hee Sam Na, Na‐Yeon Jung, Yuri Song, et al.
Journal Of Clinical Periodontology (2023) Vol. 51, Iss. 1, pp. 43-53
Open Access | Times Cited: 17
A Systematic Review on Drugs Acting as Nicotinic Acetylcholine Receptor Agonists in the Treatment of Dementia
Alessio Crestini, Elena Carbone, Roberto Rivabene, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 237-237
Open Access | Times Cited: 7
Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease
Ramón Cacabelos
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 8, pp. 673-701
Closed Access | Times Cited: 42
The Vagal Autonomic Pathway of COVID-19 at the Crossroad of Alzheimer’s Disease and Aging: A Review of Knowledge
Claire-Marie Rangon, Slavica Krantic, Emmanuel Moyse, et al.
Journal of Alzheimer s Disease Reports (2020) Vol. 4, Iss. 1, pp. 537-551
Open Access | Times Cited: 40
Mechanisms Underlying Brain Aging Under Normal and Pathological Conditions
Menglong Jin, Shi‐Qing Cai
Neuroscience Bulletin (2022) Vol. 39, Iss. 2, pp. 303-314
Open Access | Times Cited: 23
taVNS Alleviates Sevoflurane-Induced Cognitive Dysfunction in Aged Rats Via Activating Basal Forebrain Cholinergic Neurons
Qi Zhou, Zilei Zheng, Xupeng Wang, et al.
Neurochemical Research (2023) Vol. 48, Iss. 6, pp. 1848-1863
Closed Access | Times Cited: 13
Marine fungal metabolite butyrolactone I prevents cognitive deficits by relieving inflammation and intestinal microbiota imbalance on aluminum trichloride-injured zebrafish
Yingying Nie, Jingming Yang, Longjian Zhou, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 22
The Human-Restricted Isoform of the α7 nAChR, CHRFAM7A: A Double-Edged Sword in Neurological and Inflammatory Disorders
Simona Di Lascio, Diego Fornasari, Roberta Benfante
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3463-3463
Open Access | Times Cited: 22
IL-1β, the first piece to the puzzle of sepsis-related cognitive impairment?
Qing Zhu, Li Wan, Han Huang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
Evaluation of terpenes rich Hura crepitans extract on glucose regulation and diabetic complications in STZ-induced diabetic rats
Halimat Yusuf Lukman, Yu-Cheng Kuo, Mayowa Solomon Owolabi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117308-117308
Open Access | Times Cited: 4
Differential senolytic inhibition of normal versus Aβ-associated cholinesterases: implications in aging and Alzheimer’s disease
Sultan Darvesh, Meghan K. Cash, Katrina Forrestall, et al.
Aging (2025)
Open Access
SAM Alleviates Neuroinflammation by Regulating M1/M2 Polarization of Microglia Through α7nAChR/Nrf2/HO-1 Signaling Pathway
Kang Ma, Jiandong Niu, Liang Zeng, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
3-(3-(diethylamino)propyl)-2-(4-(methylthio)phenyl)thiazolidin-4-one Attenuates Scopolamine-induced Cognitive Impairment in Rats: Insights Into Neuroprotective Effects
Anita Ávila de Souza, Kelen Cristiane Machado Goularte, Raphaela Cassol Piccoli, et al.
Molecular Neurobiology (2025)
Closed Access
Page 1 - Next Page

Scroll to top